TCL Archive Phase III Study: Rituxan Improved PFS By 79% In Advanced Follicular Lymphoma December 31, 2010
TCL Archive NCI Programs: Director Challenges Scientists To Develop Molecular “Fingerprints” Of Tumors December 4, 1998
TCL Archive FDA Revokes Avastin’s Accelerated Approval In Metastatic Breast Cancer Indication November 18, 2011
TCL Archive Bush Nominates von Eschenbach For FDA; Democrats Put Hold On Confirmation. von Eschenbach To Step Down As NCI Director, But Details Unavailable; No Acting Director Named. Applause, Outrage, Over Nomination. Now, von Eschenbach Leads A Retreat From 2015 Target Date For His Challenge Goal. March 17, 2006